- Total Revenues of $60.4 Billion Grew by 7% or $3.8 Billion
Year-over-Year
- Operating Earnings Grew 9% to $5.0 Billion, Including
Double-Digit Growth Rates in Each Optum Business
- Net Earnings Per Share were $3.67, Adjusted Net Earnings Per
Share were $3.88, Bringing Year-To-Date Growth to 17%
- Cash Flows from Operations were $3.2 Billion in the Quarter,
Bringing Year-To-Date Cash Flows from Operations to $12.3 Billion
or 1.2x Net Income
Strong and diversified performance continued across UnitedHealth
Group (NYSE: UNH) in the third quarter 2019.
“Optum and UnitedHealthcare are driving value for our customers,
creating momentum to finish the year strongly and move into 2020
with an intense focus on accelerating the growth of our businesses
by advancing quality, affordability and satisfaction for those we
serve,” said David S. Wichmann, chief executive officer of
UnitedHealth Group.
Based on strong third quarter 2019 results and its positive view
for the rest of the year, the Company increased its full year net
earnings outlook to $14.15 to $14.25 per share and adjusted net
earnings to a range of $14.90 to $15.00 per share, both increasing
$0.15 per share at the mid-point.
Quarterly Financial Performance
Three
Months Ended
September 30,
2019
September 30,
2018
June 30,
2019
Revenues
$60.4 billion
$56.6 billion
$60.6 billion
Earnings from Operations
$5.0 billion
$4.6 billion
$4.7 billion
Net Margin
5.9%
5.6%
5.4%
- UnitedHealth Group’s third quarter 2019 revenues grew $3.8
billion or 6.7 percent year-over-year to $60.4 billion, led by
double-digit percentage revenue growth for Optum. Year-to-date
revenues grew 8 percent or $13.4 billion to $181.3 billion
year-over-year.
- Third quarter earnings from operations grew $424 million
year-over-year or 9.2 percent to $5.0 billion led by double-digit
growth rates across each of the Optum businesses. Adjusted net
earnings of $3.88 per share increased 13.8 percent, bringing
year-to-date adjusted net earnings per share to $11.22, a 16.9
percent growth rate year-over-year.
- Cash flows from operations were $3.2 billion in the quarter and
$12.3 billion or 1.2x net income year-to-date.
- Third quarter medical cost trends remained in line with
expectations, with the health insurance tax deferral driving the
140 basis point year-over-year increase in the medical care ratio
to 82.4 percent. Favorable medical reserve development was $140
million in the quarter, with $80 million related to 2019 and $60
million related to prior periods. Days claims payable of 49.3 days
compared to 48.6 in the second quarter 2019 and 50.5 in the third
quarter 2018.
- The third quarter operating cost ratio improved 20 basis points
from the same period last year to 14.8 percent, reflecting the
deferral of the health insurance tax and continued effects of
operating cost productivity improvements, net of the effect of
business mix changes and continued investments in innovation,
service and growth.
- Third quarter dividends of $1.08 per share increased 20 percent
year-over-year to $1 billion. The Company repurchased 2.6 million
shares for $600 million in the quarter, bringing year-to-date
purchases to 20.8 million shares for $5.1 billion.
- Return on equity of 26.2 percent in the period continued to
reflect the Company’s efficient capital base and strong earnings
profile.
UnitedHealthcare provides health care benefits globally, serving
individuals and employers, and Medicare and Medicaid beneficiaries.
UnitedHealthcare is dedicated to improving the value health care
consumers receive by reducing the total cost of care, enhancing the
quality of care received, improving health and wellness and
simplifying the health care experience.
Quarterly Financial Performance
Three
Months Ended
September 30,
2019
September 30,
2018
June 30,
2019
Revenues
$48.1 billion
$45.9 billion
$48.6 billion
Earnings from Operations
$2.7 billion
$2.6 billion
$2.6 billion
Operating Margin
5.5%
5.6%
5.4%
- UnitedHealthcare grew to serve 415,000 more people with medical
benefits over the past year driven by growth in commercial and
Medicare Advantage membership, and with greater focus on serving
people with higher acuity needs. This led to revenue growth of 4.7
percent, or $2.2 billion, to $48.1 billion in the quarter. Third
quarter 2019 earnings from operations at UnitedHealthcare grew by
3.8 percent to $2.7 billion driven by revenue growth and strong
cost disciplines, offset by an extra day in the quarter and the
impact of the health insurance tax deferral. Year-to-date, earnings
from operations grew 13 percent.
- Third quarter 2019 revenues at UnitedHealthcare Employer & Individual grew
$557 million year-over-year to $14.3 billion, as UnitedHealthcare
served just over 1 million more people with commercial benefits in
the past year.
- UnitedHealthcare Medicare &
Retirement third quarter 2019 revenues advanced by 10.2
percent or $1.9 billion to $20.7 billion. Seniors served through
Medicare Advantage grew by 315,000 over the last year to 5.23
million. Including those dually eligible for Medicare and Medicaid
and served through UnitedHealthcare Community & State, total
year-over-year growth in Medicare Advantage was nearly 450,000
people.
- Revenues at UnitedHealthcare Community
& State decreased $384 million to $10.7 billion in third
quarter 2019, as third quarter membership declined 665,000 people
year-over-year due to proactive market withdrawals as well as
states balancing carriers and managing eligibility.
- UnitedHealthcare Global third
quarter 2019 revenues increased 3.6 percent year-over-year to $2.4
billion.
Optum is a health services business serving the global health
care marketplace, including payers, care providers, health systems,
employers, governments, life sciences companies and consumers.
Using market-leading information, data analytics, technology and
clinical insights, Optum helps improve overall health system
performance: optimizing care quality, reducing health care costs
and improving the consumer and physician experience.
Quarterly Financial Performance
Three
Months Ended
September 30,
2019
September 30,
2018
June 30,
2019
Revenues
$28.8 billion
$25.4 billion
$28.0 billion
Earnings from Operations
$2.4 billion
$2.0 billion
$2.1 billion
Operating Margin
8.2%
8.0%
7.5%
- Optum third quarter 2019 revenues grew by 13.3 percent or $3.4
billion year-over-year to $28.8 billion. Optum’s third quarter 2019
earnings from operations advanced 16.1 percent to $2.4 billion.
Year-to-date, earnings from operations grew 15 percent.
- OptumHealth revenues in the third
quarter 2019 of $8.1 billion grew 34.4 percent year-over-year or
$2.1 billion, with strength and diversity of growth across care
delivery and expansion of behavioral health services. OptumHealth
served approximately 95 million people at September 30, 2019, as
revenue per consumer increased 30 percent year-over-year, driven by
growth in value-based care arrangements and expanded local care
delivery offerings.
- Third quarter 2019 revenues at OptumInsight grew 16.1 percent year-over-year to
$2.6 billion, while revenue backlog advanced 21 percent
year-over-year to $19.0 billion at quarter-end.
- OptumRx revenues in third quarter
2019 of $18.5 billion increased 5.8 percent or $1.0 billion
year-over-year, reflecting continued diversification to more
clinically focused services, including specialty pharmacy care. In
the third quarter 2019 OptumRx fulfilled 325 million adjusted
scripts or a decline of 2 percent over the prior year, impacted by
the one previously announced large client transition.
About UnitedHealth Group
UnitedHealth Group (NYSE: UNH) is a diversified health care
company dedicated to helping people live healthier lives and
helping make the health system work better for everyone.
UnitedHealth Group offers a broad spectrum of products and services
through two distinct platforms: UnitedHealthcare, which provides
health care coverage and benefits services; and Optum, which
provides information and technology-enabled health services. For
more information, visit UnitedHealth Group at
www.unitedhealthgroup.com or follow @UnitedHealthGrp on
Twitter.
Earnings Conference Call
As previously announced, UnitedHealth Group will discuss the
Company’s results, strategy and future outlook on a conference call
with investors at 8:45 a.m. Eastern Time today. UnitedHealth Group
will host a live webcast of this conference call from the Investors
page of the Company’s website (www.unitedhealthgroup.com).
Following the call, a webcast replay will be available on the same
site through October 29, 2019. The conference call replay can also
be accessed by dialing 1-800-839-1162. This earnings release and
the Form 8-K dated October 15, 2019, can also be accessed from the
Investors page of the Company’s website.
Non-GAAP Financial
Information
This news release presents non-GAAP financial information
provided as a complement to the results provided in accordance with
accounting principles generally accepted in the United States of
America (“GAAP”). A reconciliation of the non-GAAP financial
information to the most directly comparable GAAP financial measure
is provided in the accompanying tables found at the end of this
release.
Forward-Looking
Statements
The statements, estimates, projections, guidance or outlook
contained in this document include “forward-looking” statements
which are intended to take advantage of the “safe harbor”
provisions of the federal securities law. The words “believe,”
“expect,” “intend,” “estimate,” “anticipate,” “forecast,”
“outlook,” “plan,” “project,” “should” and similar expressions
identify forward-looking statements. These statements may contain
information about financial prospects, economic conditions and
trends and involve risks and uncertainties. Actual results could
differ materially from those that management expects, depending on
the outcome of certain factors including: our ability to
effectively estimate, price for and manage medical costs; new or
changes in existing health care laws or regulations, or their
enforcement or application; the DOJ’s legal action relating to the
risk adjustment submission matter; our ability to maintain and
achieve improvement in quality scores impacting revenue; reductions
in revenue or delays to cash flows received under government
programs; changes in Medicare, the CMS star ratings program or the
application of risk adjustment data validation audits;
cyber-attacks, other privacy/data security incidents, or our
failure to comply with related regulations; risks and uncertainties
associated with the pharmacy benefits management industry;
competitive pressures; changes in or challenges to our public
sector contract awards; our ability to contract on competitive
terms with physicians, hospitals and other service providers;
failure to achieve targeted operating cost productivity
improvements; increases in costs and other liabilities associated
with litigation, government investigations, audits or reviews;
failure to manage successfully our strategic alliances or complete
or receive anticipated benefits of strategic transactions;
fluctuations in foreign currency exchange rates; downgrades in our
credit ratings; our investment portfolio performance; impairment of
our goodwill and intangible assets; failure to maintain effective
and efficient information systems or if our technology products do
not operate as intended; and our ability to obtain sufficient funds
from our regulated subsidiaries or from external financings to fund
our obligations, maintain our debt to total capital ratio at
targeted levels, maintain our quarterly dividend payment cycle, or
continue repurchasing shares of our common stock. This above list
is not exhaustive. We discuss these matters, and certain risks that
may affect our business operations, financial condition and results
of operations more fully in our filings with the SEC, including our
reports on Forms 10-K, 10-Q and 8-K. By their nature,
forward-looking statements are not guarantees of future performance
or results and are subject to risks, uncertainties and assumptions
that are difficult to predict or quantify. Actual results may vary
materially from expectations expressed or implied in this document
or any of our prior communications. You should not place undue
reliance on forward-looking statements, which speak only as of the
date they are made. We do not undertake to update or revise any
forward-looking statements, except as required by law.
UNITEDHEALTH GROUP Earnings Release Schedules and
Supplementary Information Quarter Ended September 30,
2019 - Condensed Consolidated Statements of Operations -
Condensed Consolidated Balance Sheets - Condensed Consolidated
Statements of Cash Flows - Supplemental Financial Information -
Businesses - Supplemental Financial Information - Business Metrics
- Reconciliation of Non-GAAP Financial Measure
UNITEDHEALTH GROUP
CONDENSED CONSOLIDATED
STATEMENTS OF OPERATIONS
(in millions, except per share
data)
(unaudited)
Three Months Ended September
30,
Nine Months Ended September
30,
2019
2018
2019
2018
Revenues Premiums
$
47,397
$
44,613
$
142,074
$
133,155
Products
7,546
7,344
23,971
21,050
Services
4,942
4,217
13,756
12,590
Investment and other income
466
382
1,453
1,035
Total revenues
60,351
56,556
181,254
167,830
Operating costs Medical costs
39,041
36,158
117,164
108,448
Operating costs
8,960
8,479
25,892
25,371
Cost of products sold
6,627
6,718
21,606
19,373
Depreciation and amortization
709
611
2,002
1,791
Total operating costs
55,337
51,966
166,664
154,983
Earnings from operations
5,014
4,590
14,590
12,847
Interest expense
(449
)
(353
)
(1,267
)
(1,026
)
Earnings before income taxes
4,565
4,237
13,323
11,821
Provision for income taxes
(936
)
(953
)
(2,752
)
(2,603
)
Net earnings
3,629
3,284
10,571
9,218
Earnings attributable to noncontrolling interests
(91
)
(96
)
(273
)
(272
)
Net earnings attributable to UnitedHealth Group common
shareholders
$
3,538
$
3,188
$
10,298
$
8,946
Diluted earnings per share attributable to UnitedHealth
Group common shareholders
$
3.67
$
3.24
$
10.65
$
9.09
Adjusted earnings per share attributable to UnitedHealth
Group common shareholders (a)
$
3.88
$
3.41
$
11.22
$
9.60
Diluted weighted-average common shares outstanding
963
983
967
984
(a) See page 6 for a reconciliation of the non-GAAP measure
UNITEDHEALTH GROUP
CONDENSED CONSOLIDATED BALANCE
SHEETS
(in millions)
(unaudited)
September 30,
December 31,
2019
2018
Assets Cash and short-term investments
$
15,818
$
14,324
Accounts receivable, net
10,964
11,388
Other current assets
16,759
12,980
Total current assets
43,541
38,692
Long-term investments
36,840
32,510
Other long-term assets
93,328
81,019
Total assets
$
173,709
$
152,221
Liabilities, redeemable noncontrolling interests
and equity Medical costs payable
$
20,939
$
19,891
Commercial paper and current maturities of long-term debt
6,387
1,973
Other current liabilities
35,315
31,345
Total current liabilities
62,641
53,209
Long-term debt, less current maturities
38,507
34,581
Other long-term liabilities
12,814
8,204
Redeemable noncontrolling interests
1,991
1,908
Equity
57,756
54,319
Total liabilities, redeemable noncontrolling interests and
equity
$
173,709
$
152,221
UNITEDHEALTH GROUP
CONDENSED CONSOLIDATED
STATEMENTS OF CASH FLOWS
(in millions)
(unaudited)
Nine Months Ended September
30,
2019
2018
Operating Activities Net earnings
$
10,571
$
9,218
Noncash items: Depreciation and amortization
2,002
1,791
Deferred income taxes and other
(4
)
(127
)
Share-based compensation
525
512
Net changes in operating assets and liabilities
(836
)
1,923
Cash flows from operating activities
12,258
13,317
Investing Activities Purchases of investments, net of
sales and maturities
(2,028
)
(3,729
)
Purchases of property, equipment and capitalized software
(1,421
)
(1,505
)
Cash paid for acquisitions, net
(8,200
)
(5,824
)
Other, net
338
(187
)
Cash flows used for investing activities
(11,311
)
(11,245
)
Financing Activities Common share repurchases
(5,101
)
(3,650
)
Dividends paid
(2,908
)
(2,454
)
Net change in commercial paper and long-term debt
8,192
1,200
Other, net
404
1,211
Cash flows from (used for) financing activities
587
(3,693
)
Effect of exchange rate changes on cash and cash equivalents
(37
)
(97
)
Increase (decrease) in cash and cash equivalents
1,497
(1,718
)
Cash and cash equivalents, beginning of period
10,866
11,981
Cash and cash equivalents, end of period
$
12,363
$
10,263
UNITEDHEALTH GROUP
SUPPLEMENTAL FINANCIAL
INFORMATION - BUSINESSES
(in millions, except
percentages)
(unaudited)
Three Months Ended September
30,
Nine Months Ended September
30,
2019
2018
2019
2018
Revenues UnitedHealthcare
$
48,105
$
45,937
$
145,595
$
137,242
Optum
28,763
25,391
83,152
73,718
Eliminations
(16,517
)
(14,772
)
(47,493
)
(43,130
)
Total consolidated revenues
$
60,351
$
56,556
$
181,254
$
167,830
Earnings from Operations UnitedHealthcare
$
2,655
$
2,559
$
8,251
$
7,316
Optum (a)
2,359
2,031
6,339
5,531
Total consolidated earnings from operations
$
5,014
$
4,590
$
14,590
$
12,847
Operating Margin UnitedHealthcare
5.5
%
5.6
%
5.7
%
5.3
%
Optum
8.2
%
8.0
%
7.6
%
7.5
%
Consolidated operating margin
8.3
%
8.1
%
8.0
%
7.7
%
Revenues UnitedHealthcare Employer &
Individual
$
14,291
$
13,734
$
42,407
$
40,856
UnitedHealthcare Medicare & Retirement
20,698
18,789
62,649
56,573
UnitedHealthcare Community & State
10,670
11,054
33,038
32,471
UnitedHealthcare Global
2,446
2,360
7,501
7,342
OptumHealth
$
8,133
$
6,052
$
21,994
$
17,752
OptumInsight
2,617
2,254
7,145
6,508
OptumRx
18,454
17,437
55,194
50,484
Optum eliminations
(441
)
(352
)
(1,181
)
(1,026
)
(a)
Earnings from operations for Optum for the three and nine
months ended September 30, 2019 included $748 and $2,062 for
OptumHealth; $632 and $1,589 for OptumInsight; and $979 and $2,688
for OptumRx, respectively. Earnings from operations for Optum for
the three and nine months ended September 30, 2018 included $622
and $1,680 for OptumHealth; $534 and $1,382 for OptumInsight; and
$875 and $2,469 for OptumRx, respectively.
UNITEDHEALTH
GROUP SUPPLEMENTAL FINANCIAL INFORMATION - BUSINESS
METRICS UNITEDHEALTHCARE CUSTOMER PROFILE (in
thousands)
People Served September 30,2019
June 30,2019 December 31,2018 September
30,2018 Commercial: Risk-based
8,605
8,325
8,495
8,450
Fee-based
19,230
19,090
18,420
18,365
Total Commercial
27,835
27,415
26,915
26,815
Medicare Advantage
5,230
5,190
4,945
4,915
Medicaid
5,965
6,360
6,450
6,630
Medicare Supplement (Standardized)
4,510
4,495
4,545
4,540
Total Public and Senior
15,705
16,045
15,940
16,085
Total UnitedHealthcare - Domestic Medical
43,540
43,460
42,855
42,900
International
5,845
6,070
6,220
6,070
Total UnitedHealthcare - Medical
49,385
49,530
49,075
48,970
Supplemental Data Medicare Part D stand-alone
4,415
4,430
4,710
4,725
OPTUM PERFORMANCE METRICS September
30,2019 June 30,2019 December 31,2018
September 30,2018 OptumHealth Consumers Served (in
millions)
95
95
93
92
OptumInsight Contract Backlog (in billions)
$
19.0
$
18.5
$
17.0
$
15.7
OptumRx Quarterly Adjusted Scripts (in millions)
325
343
348
331
Note: UnitedHealth Group served 136 million unique
individuals across all businesses at September 30, 2019.
UNITEDHEALTH GROUP
RECONCILIATION OF NON-GAAP
FINANCIAL MEASURE
(in millions, except per share
data)
(unaudited)
ADJUSTED NET EARNINGS PER
SHARE(a)
Three Months Ended September
30,
Nine Months Ended September
30,
Projected Year Ended December
31,
2019
2018
2019
2018
2019
GAAP net earnings attributable to UnitedHealth Group common
shareholders
$
3,538
$
3,188
$
10,298
$
8,946
$13,650 - $13,750
Intangible amortization
262
221
729
661
~1,000
Tax effect of intangible amortization
(64
)
(54
)
(180
)
(165
)
~(245)
Adjusted net earnings attributable to UnitedHealth
Group common shareholders
$
3,736
$
3,355
$
10,847
$
9,442
$14,405 - $14,505
GAAP diluted earnings per share
$
3.67
$
3.24
$
10.65
$
9.09
$14.15 - $14.25
Intangible amortization per share
0.27
0.22
0.75
0.67
~1.00
Tax effect per share of intangible amortization
(0.06
)
(0.05
)
(0.18
)
(0.16
)
~(0.25)
Adjusted diluted earnings per share
$
3.88
$
3.41
$
11.22
$
9.60
$14.90 - $15.00
(a)
Adjusted net earnings per share is a non-GAAP financial measure.
Non-GAAP financial measures should be considered in addition to,
but not as a substitute for, or superior to, financial measures
prepared in accordance with GAAP. Adjusted net earnings per share
excludes from the relevant GAAP metric, as applicable, intangible
amortization and other items, if any, that do not relate to the
Company's underlying business performance. Management believes that
the use of adjusted net earnings per share provides investors and
management useful information about the earnings impact of
acquisition-related intangible asset amortization. As amortization
fluctuates based on the size and timing of the Company’s
acquisition activity, management believes this exclusion provides a
more useful comparison of the Company's underlying business
performance and trends from period to period. While intangible
assets contribute to the Company’s revenue generation, the
intangible amortization is not directly related. Therefore, the
related revenues are included in adjusted earnings per share.
Click here to subscribe to Mobile Alerts for UnitedHealth
Group.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191015005470/en/
Investors: Brett Manderfeld Senior Vice President
952-936-7216
Media: Matt Stearns Senior Vice President
202-276-0085
UnitedHealth (NYSE:UNH)
Historical Stock Chart
From Mar 2024 to Apr 2024
UnitedHealth (NYSE:UNH)
Historical Stock Chart
From Apr 2023 to Apr 2024